Gardasil, the often controversial vaccine against human papillomavirus (HPV), which is given to young women, has been found to be quite effective in preventing male warts.
Gardasil helps reduce the risk of developing cervical cancer by preventing certain types HPV infection. Although there are many types of HPV, Gardasil protects against the three most serious ones that are implicated in cervical cancer.
Two of the strains of HPV that are also known to cause rare warts on men are among the three that the vaccine prevents. According to the FDA, the vaccine can prevent these genital warts in men 90% of the time.
More studies need to be done, but the maker of Gardasil, Merck, is asking that the FDA consider granting approval so they can market the vaccine to males aged 9 years to 26 years.